These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24589204)

  • 1. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature.
    Bester L; Meteling B; Boshell D; Chua TC; Morris DL
    J Med Imaging Radiat Oncol; 2014; 58(3):341-52. PubMed ID: 24589204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial therapy of neuroendocrine tumour liver metastases: comparing conventional TACE, drug-eluting beads TACE and yttrium-90 radioembolisation as treatment options using a propensity score analysis model.
    Do Minh D; Chapiro J; Gorodetski B; Huang Q; Liu C; Smolka S; Savic LJ; Wainstejn D; Lin M; Schlachter T; Gebauer B; Geschwind JF
    Eur Radiol; 2017 Dec; 27(12):4995-5005. PubMed ID: 28677067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolization for primary and metastatic liver cancer.
    Liapi E; Geschwind JF
    Cancer J; 2010; 16(2):156-62. PubMed ID: 20404613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation.
    Klompenhouwer EG; Dresen RC; Verslype C; Laenen A; De Hertogh G; Deroose CM; Bonne L; Vandevaveye V; Maleux G
    Cardiovasc Intervent Radiol; 2017 Dec; 40(12):1882-1890. PubMed ID: 28685382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter intraarterial therapies: rationale and overview.
    Lewandowski RJ; Geschwind JF; Liapi E; Salem R
    Radiology; 2011 Jun; 259(3):641-57. PubMed ID: 21602502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
    Nazario J; Gupta S
    Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads.
    Guiu B; Deschamps F; Aho S; Munck F; Dromain C; Boige V; Malka D; Leboulleux S; Ducreux M; Schlumberger M; Baudin E; de Baere T
    J Hepatol; 2012 Mar; 56(3):609-17. PubMed ID: 22027582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
    Burrel M; Reig M; Forner A; Barrufet M; de Lope CR; Tremosini S; Ayuso C; Llovet JM; Real MI; Bruix J
    J Hepatol; 2012 Jun; 56(6):1330-5. PubMed ID: 22314428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
    Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
    Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study.
    Fiorentini G; Aliberti C; Del Conte A; Tilli M; Rossi S; Ballardini P; Turrisi G; Benea G
    In Vivo; 2009; 23(1):131-7. PubMed ID: 19368137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
    Tai D; Loke K; Gogna A; Kaya NA; Tan SH; Hennedige T; Ng D; Irani F; Lee J; Lim JQ; Too CW; Ng MCH; Tham CK; Lam J; Koo SL; Chong HS; Goh GB; Huang HL; Venkatanarasimha N; Lo R; Chow PKH; Goh BKP; Chung A; Toh HC; Thng CH; Lim TKH; Yeong J; Zhai W; Chan CY; Choo SP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1025-1035. PubMed ID: 34695377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
    Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
    J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-Directed Therapies for Neuroendocrine Neoplasms.
    Clift AK; Frilling A
    Curr Oncol Rep; 2021 Mar; 23(4):44. PubMed ID: 33721122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy.
    Kouri BE
    Tech Vasc Interv Radiol; 2018 Dec; 21(4):205-222. PubMed ID: 30545499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
    Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases.
    Bester L; Meteling B; Pocock N; Saxena A; Chua TC; Morris DL
    J Med Imaging Radiat Oncol; 2013 Feb; 57(1):72-80. PubMed ID: 23374558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial therapies for unresectable and chemorefractory colorectal cancer liver metastases: a systematic review and meta-analysis.
    Levy J; Zuckerman J; Garfinkle R; Acuna SA; Touchette J; Vanounou T; Pelletier JS
    HPB (Oxford); 2018 Oct; 20(10):905-915. PubMed ID: 29887263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.
    Takayasu K
    Oncology; 2013; 84 Suppl 1():28-33. PubMed ID: 23428855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.